期刊文献+

CB和MMP-2在上皮性卵巢癌中的表达及其相关性的研究 被引量:4

Expression and relationship of CB、MMP-2 in epithelial ovarian carcinoma
下载PDF
导出
摘要 目的:探讨组织蛋白酶B(cathepsin B,CB)和基质金属蛋白酶-2(matrix metalloproteinases-2,MMP-2)在上皮性卵巢癌中的表达及其相关性。方法:采用免疫组化法检测60例上皮性卵巢癌组织、20例卵巢良性肿瘤、20例交界性上皮性卵巢肿瘤以及10例正常卵巢组织中CB和MMP-2的表达情况。结果:CB和MMP-2在正常卵巢组织、卵巢良性肿瘤、卵巢交界性肿瘤、上皮性卵巢癌中表达水平呈明显上升趋势,CB和MMP-2在上皮性卵巢癌中的表达与组织病理分级、淋巴结转移均呈正相关,与临床分期、组织学分型无关。二者在上皮性卵巢癌中的表达呈正相关。结论:CB和MMP-2表达升高在上皮性卵巢癌的发生、分化、进展过程中起重要的作用。 Objective:To study the expression and relationship of CB and MMP -2 in epithelial ovarian carcinoma. Methods : Immunohistochemieal staining S - P method was used to detect the expression of CB and MMP - 2 in 60 cases of epithelial ovarian carcinoma,20 cases of benign ovarian tissue,20 cases of borderline ovarian tumor and 10 cases of normal ovarian tissue . Results : The expression level of CB and MMP - 2 was obviously increased ( P 〈 0.001 ) in normal ovarian tissue, borderline ovarian tumor and epithelial ovarian carcinoma. The expressions of CB and MMP -2 were in positive correlation with tumor grade and lymphatic metastasis. ,while no correlation with tumor stage and histological grading. There was significant positive correlation between CB and MMP -2 in epithelial ovarian carcinoma. Conclusion : The increased expression of CB and MMP - 2 may play an important role in the process of carcinogenesis, progression and differentiation of epithelial ovarian carcinoma. CB and MMP- 2 may be useful targets for treatment of ovarian carcinoma.
出处 《现代肿瘤医学》 CAS 2010年第3期536-538,共3页 Journal of Modern Oncology
基金 辽宁教育厅高等学校科研项目(208776) 辽宁省教育厅高等学校科研项目(05L475) 沈阳市科委科学技术项目(1081239)
关键词 组织蛋白酶B 基质金属蛋白酶-2 上皮性卵巢肿瘤 免疫组织化学 CB MMP - 2 epithelial ovarian carcinoma immunohistochemicatry
  • 相关文献

参考文献11

  • 1Koblinski JE, Ahram M, Sloane BF. Unraveling the role of proteases in cancer[J]. Clin Chim Acta,2000,291 (2) :113 -135.
  • 2Ishidoh K, Kominami E. Processing and activation of Lysosomal proteinases [ J ]. Biol Chem,2002,383 ( 12 ) : 1827 - 1831.
  • 3Fernandez PL, Farre X, Nadal A, et al. Expression of cathepsin B and S in the progression of prostate carcinoma[ J]. Int J Cancer, 2001,95(1) :51 -55.
  • 4Halangk W, Lerch MM, Brandt - Nedelev B, et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis [ J ]. Clin Invest, 2000,106 (6) :773 - 781.
  • 5Yan S, Sloane BF. Molecular regulation of human Cathepsin B: imolication in pathologies [ J ]. Biol Chem, 2003,384 (6) : 845 - 854.
  • 6Sloane BF,Yan S, Podgorski I,et al. Cathepsin B and tumor proteolysis :contribution of the tumor microenvironment [ J]. Semin Cancer Biol,2005,15(2) :149 -157.
  • 7Premzl A,Zavasnik Bergant V,Turk V, et al. Intraeellular and extracellular Cathepsin B facilitate invasion of MCF - 10A neoT ceils through reconstituted extracellular matrix in vitro [ J ]. Exp Cell Res,2003,283 (2) :206 - 214.
  • 8Quaranta M, Daniele A, Coviello M,et al. MMP - 2 and MMP - 9. VEGF and CA153 in breast cancer [J]. Anticancer Res,2007,27 (5B) :3593.
  • 9Koyama S. Enhanced cell surface expression of matrixmetalloproteinases and their in hibitors, and tumor - induced host response in progression of human gastric carcinoma [ J ]. Digis SCI, 2004,49 (10) : 1621 - 1630.
  • 10李治,帅晓明,黄韬.MMP-2、MMP-9在乳腺癌转移中作用的研究[J].华西医学,2006,21(1):43-44. 被引量:17

二级参考文献9

  • 1Yu Q,Stamenkovic I.Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis[J].Genes,2000,14(2):163-76.
  • 2Lhotak S,Elavathil LJ,Vukmirovic-Popovic,et al.Immunolocalization of matrix-metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma[J].Clin Exp Metastasis,2000,18(6):463-70.
  • 3Lee PP,Hwang JJ,Murphu G,et al.Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells[J].Endocrinology,2000,141(10):3764-73.
  • 4Canning MT,Postovit LM,Clarke SH,et al.Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells[J].Exp Cell Res,2001,267(1):88-94.
  • 5Care A,Felicetti F,Meccia E,et al.HOXB7:a key factor for tumor-associated angiogenic switch[J].Cancer Res,2001,61(17):6532-9.
  • 6Kondo S,Kubota S,Shimo T,et al.Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases[J].Carcinogenesis,2002,23(5):769-76.
  • 7Pacheco MM,Nishimoto IN,Mourao Neto M,et al.Prognostic significance of the combined expression of matrix metalloproteinase-9,urokinase type plasminogen activator and its receptor in breast cancer as measured by Northern blot analysis[J].Int J Biol Markers,2001,16(1):62-8.
  • 8Scorilas A,Karameris A,Arnogiannaki N,et al.Overexpression of matrix-metalloproteinase-9 in human breast cancer:a potential favourable indicator in node-negative patients[J].Br J Cancer,2001,84(11):1488-96.
  • 9Talvensaari-Mattila A,Paakko P.Turpeenniemi-Hujanen T;MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma[J].Breast Cancer Res Treat,1999,58(3):287-93.

共引文献16

同被引文献36

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部